Molecular cloning of a human thyrotropin receptor cDNA fragment Use of highly degenerate, inosine containing primers derived from aligned amino acid sequences of a homologous family of glycoprotein hormone receptors by Huang, Guo Cai et al.
Volume 264, number 2, 193-197 FBBS 08423 May 1990 
Molecular cloning of a human thyrotropin receptor cDNA fragment 
Use of highly degenerate, inosine containing primers derived from aligned amino 
acid sequences of a homologous family of glycoprotein hormone receptors 
Guo Cai Huangl, Martin J. Page”, Andrew J. Robe&, Afshan N. Malikl, Hugh Spenc8, 
Alan M. McGregor1 and J. Paul Bangal 
1 Departme& of Medicine, King S College School f Medicine, Denmark Hii& Lartdon SE5 &RX, UK and 2 Wellcome Research 
Laboratories, Wel~come &tech, Langley Park Road, ~ekenham, Kent RR3 3BS, UK 
Received 12 March 1990 
Autoantibodies to the thyrotropin (TSH) hormone receptor (TSH-R) are present in the sera of patients with thyroid autoimmune disease which 
are pathogenetic leading to hyperthyroidism of Graves’ disease. Considerable interest has been focused on the cloning of the human TSH-R, which 
has until very recently, proven exceedingly difficult due to the very low receptor level expression on thyroid cells. We have used. polymerase chain 
reaction and highly degenerate, inosine cont~~ng oligonucleot~des derived from sequence ali~men~ of the transmembrane r gions 2 and 7 of 
a number of G-binding protein receptors including the Iutropin/choriogonadotropin (LH/CG} receptors to amplify various cDNAs from human 
thyroid cDNA. Sequencing analysis of 27 different clones revealed that they fall into eight different groups. The very recent publication of the 
complete nucleotide sequence of the human TSH-R revealed that one of the groups (GTl) containing seven clones which had been sequenced belong 
to the human TSH-receptor. The sequence of all 7 GTI clones was identical and in complete concordance with transmembrane r gions 2 and 7 
of the published TSH-R sequence. Our results show that by designing oligonucleotides to common transmembrane r gions of G-binding proteins 
where the primers are biased in their sequence to the LH,CG receptors it is possible to amplify the TSH-R receptor sequence. 
TSH receptor, human; Polymerase chain reaction; Graves’ disease; G-binding protein receptor 
1. INTRODUCTION 
The receptor for thyroid stimulating hormone (TSH- 
R), found on the basal surface of the thyroid follicular 
cells, governs thyroid cell function and growth [1,2]. 
Physiological activation of the TSH-R by the pituitary 
hormone thyrotropin (TSH) enhances adenyl cyclase 
activity leading to increased thyroid hormone synthesis 
and thyroid cell growth [3]. The human TSH-R (hTSH- 
R) is the target of attack in autoimmune thyroid disease 
with aberrant stimulation of the receptor by autoan- 
tibodies leading to the hyperthyroidism observed in 
Graves’ disease [4-Q. 
The TSH-R has not been amenable to biochemical 
purification or molecular cloning procedures due to the 
extraordinary low levels of receptor expressed on 
thyroid cells, although the biochemical properties of the 
receptor have been studied [8]. TSH belongs to the 
glycoprotein family of hormones, which consists of two 
heterodimeric polypeptide subunits and also includes 
lutropin (LH), choriogonadotropin (CG) and 
follitropin (FSH). The cy subunit is common to all these 
hormones, of which each has a distinct 0 subunit com- 
ponent [9]. Due to this homology it is likely that the 
receptors for this glycoprotein hormone family should 
also belong to a common family. Since the biological ef- 
fects of the glycoprotein hormone family are mediated 
by CAMP, the receptors belong to the family of G- 
protein coupled receptors [lo, 111. Other members of 
this family whose sequences have been deduced by 
cDNA cloning include receptors for the crl , a2, fil and 
,&2 adrenergic and muscarinic cholinergic receptors, 
serotonin, substance K, angiotensin, dopamine and the 
opsin protein, rhodopsin [ll]. To this group of mem- 
brane proteins which traverse the membrane 7 times, a 
hallmark for guanine nucleotide binding receptors, 
have been added the complete sequences of the porcine 
and rat LH/CG receptors [ 12,131. 
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Recent technological advances in the polymerase 
chain reaction (PCR) methodology first described by 
Saiki et al [14] have resulted in two major developments 
which allow amplification and cloning of low abun- 
dance mRNAs. Firstly, the ability to use degenerate 
oligonucleotides derived from peptide sequences for 
amplification of DNA from total cDNA (termed ‘mixed 
oligonucleotide primed amplification of cDNA 
(MOPAC)‘) [1.5] and, secondly, the amplification of 
rare transcripts of cDNA using homopolymer tailing 
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(termed ‘rapid amplification of cDNA ends (RACE)‘) 
has been described [16]. In addition, Libert et al. have 
independently used amplification techniques incor- 
porating MOPAC technology together with low 
stringency hybridisation conditions to identify members 
of the G-protein coupled receptors by designing highly 
degenerate oligonucleotides to the common transmem- 
brane regions of the guanine nucleotide binding pro- 
teins 1171. Additionally, these primers incorporate in- 
osine [18]. Using this methodology on cDNA prepared 
from human thyroid gland, with highly degenerate con- 
sensus oligonucleotide primers to transmembrane 
regions 3 and 6, four new members of the G-protein 
coupled family of receptors were described. However, 
the transcript for the elusive thyrotropin receptor failed 
to be amplified with these degenerate primers [ 171. Dur- 
ing the course of the above experiments, the sequences 
for the LH/CG receptors [12,13] were not available. 
Following the publication of the LHKG receptors, 
we have attempted to clone the human TSH-R by 
employing a combination of the MOPAC technology 
1151 and a modification of the method described. By 
aligning the amino acid sequences of G-protein coupled 
receptors (including the LHKG receptors [12,13]), we 
have designed degenerate, inosine containing oligo- 
nucleotides which are different from those described in 
[17] for amplification of the TSH-R cDNA fragment 
from human thyroid mRNA. 
During the course of this work, the complete se- 
quences of dog and human TSH-R were simultaneously 
published by 3 independent groups [ 19-231. The 
publication of the hTSH-R cDNA sequences [22,23] 
enabled us to compare the sequences of the cDNA 
fragments which we had amplified directly from human 
thyroid cDNA, using highly degenerate, inosine con- 
taining oligonucleotides. This allowed us to identify our 
cDNA clones flout any functional expression data. 
We now report that using a modification of the method 
originally described [ 171, it is possible to directly 
amplify the hTSH-R from human thyroid cDNA. This 
may have applications to identifying other rare, un- 
characterised cDNA transcripts which belong to 
families of proteins in which some family member se- 
quences have been determined. 
2. MATERIALS AND METHODS 
2.1. Synthesis of degenerate and inosine containing oligonucleofides 
Oligonudeotides were synthesised on an automated synthesiser 
(Milligen 7500 DNA s~th~izer) using ~~y~~thylphosph~a~dite 
chemistry. Inosine additions were carried out using cyanoethyl deox- 
yinosine phosphoramidite where 0.25 g was dissolved in 3 ml 
anhydrous acetonitrile and placed in the 1 position of the synthesiser. 
Reactions were performed as for normal phosphor~idites but 
because of the instability of the inosine solution this was used within 
2 days of preparation. Mixed base additions were carried out using 
mixing protocols supplied with the synthesiser or, in the case of mixed 
3 ’ termini, by mixing the individual supports when packing the syn- 
thesis columns. The mixed oligonucleotides thus prepared were used 
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subsequently without any further purification by resuspending at IO 
pmol/$ in sterile water for PCR. 
2.2 Polymerase chain amplification (PCR) 
Total cellular RNA from a Graves’ thyroid gland was isolated by a 
modification of the single step acid guanidium method (241 and poly 
A+ RNA prepared 1251. Double stranded cDNA was synthesised 
from 5 gg poly A ’ RNA as template and oligo d(T) for first strand 
synthesis with Moloney Murine Leukemia virus reverse transcriptase 
using a commercial kit (Pharmacia). The resulting double stranded 
cDNA was precipitated in ethanol and after washing resupended in 20 
~1 sterile water. 
PCR was performed in a thermal cycler (Perkin Elmer Cetus) with 
2.5U Taq polymerase (Cetus) using a modi~cation of the method 
described [171. Double stranded cDNA (1~1) in 100 ~1 total volume of 
amplification buffer [14] containing a final concentration of 2 mM 
Mg’” and 40 pmol of each oligonucleotide primer were subjected to 
2.5 cycles of PCR. Bach cycle consisted of 40 s denaturation at 92”C, 
1.5 min annealing at 55’C and 3 min chain extension at 72OC. Of the 
above reaction mixture 2 ~1 were then subjected to an additional 30 
cycles of amplification under identical conditions. Following a total 
of 55 cycles, the overlying oil was removed and a 10 ~1 sample was 
electrophoresed in 1.6% agarose gel to visualize the PCR products. 
The remainder of the amplified DNA was extracted with 
phenol/chloroform, ethenol precipitated and following resuspension 
in 100 $ TE8, digested with BarnHI adn EcoRI. Following digestion, 
the amplified DNA was electrophoresed in low melting agarose gel. 
the 700 bp DNA fragment excised, eluted and purified on an Elutip-d 
column (Schleicher & Schull). 
2.3. Nucleotide sequencing and comparison of sequences 
The purified 700 bp amplified DNA was ligated into 
BamHIfEcoRi digested Ml3 (mpl8) or pBluescript SKII + and se- 
quenced by the chain termination method using a sequenase kit (US 
Biochemicals) and (or3’S)dATP (Amersham). 
Nucleotide sequences were compared using Wordsearch Program 
on the GenBMBL databank and compared with each other using the 
Bestfit Program. Both programs were from the GCG package [26]. 
3. RESULTS AND DISCUSSION 
The complete amino acid sequences of the rat and 
porcine LHKG receptors have been recently deduced 
f12,13]. The transmembrane regions showing the 
highest degree of homology with other G-protein cou- 
pled receptors were the putative transmembrane 
segments 2, 3, 6 and 7 [12,13,27]. Highly degenerate 
and inosine containing oligonucleotides were designed 
to these regions of the putative transmembrane 
segments of the aligned G-protein coupled receptors. 
Addition~ly, the design of the oligonucleotide primers 
was biased towards the transmembrane segments of the 
LHKG receptors [12,13], The final sequence of the 
degenerate, inosine-cont~ning o~gonucleotide primers 
derived from the alignments to the putative transmem- 
brane segments 2, 3, 6 and 7 are shown in Fii. 1 and 
were termed TM2, TM3, TM6 and TM7 primers, 
respectively. A BamHI restriction site in forward 
primers TM2 and TM3 and an EcoRI restriction site in 
the reverse primers TM6 and TM7 were incorporated in 
the 5’ region to facilitate subcloning. 
Amplification of different combinations of forward 
and reverse primers from thyroid double stranded 
cDNA by PCR gave a specific, amplified fragment of 
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FORWARD PRIMERS 
bRHOD I-LLNLAVADLFMVFGGFTTTLY 
hBETA1 F-IMSLASADLVMGLLWPFGAT 
hBETA2 F-ITSLACADLVMGLAWPFGAA 
hALPHA1 F-IVNLAIADLLLSFTVLPFSAT 
hALPHA2 F-LVSLASADILVATLVIPFSLA 
pm3ACH F-LLSLACADLIIGTFSMNLYTT 
bSK F-IVNLALADLCMAAFNAAFNFV 
pLH/hCG FLMCNLSFADFCMGLYLLLIASV 
rLH/hCG FLMCNLSFADFCMGLYLLLIASU 
AAT CTC TCC 111 GCA GAC TTC TGC ATG 
. . . . . . . . . . . . . . . .-. ..T --- ..- 
Consensus 
Oligo- 
nucleotide 
C GG G T TT GG C 
5’ CGA TCC AAT ITC TCC TTT CC1 GAC CT1 TTC ATG 3’ 
REVERSE PRIMERS 
bRHOD MVIIMVIAFLICWLPY---AGVAF 
hBETA1 TLGIIMGVFTLCWLP--FFLANW 
hBETA2 TLGIIMGTFTLCWLP--FFIVNIV 
hALPHA1 TLGIWGMFILCWLP--FFIALPL 
hALPHA2 VLAWIGVFWCWFP--FFFTYTL 
pm3ACH TLSIALLAFIVTWTP--YNIMVLA 
bSK TMVLVWTFAICWLPYHLYFILGT 
pLH/hCG MAVLIFTDFT-CMAPISFFAISAA 
rLH/hCG MAILIFTDFT-CMAPISFFAISAA 
TTC CCG TGC ATG ACG CCC 
_.e A-. ._m mm. G-m C.- 
Consensus 
Oligo- 
nude0 tide 
CAC A GCG AC 
3’AAG TGG GAG TIC AC1 GIC CTT AAG 5’ 
May 1990 
GFFATLGGEIALWSLWLAIERYVWC 
TSVDVLCVTASIETLCVIALDRYLAIT 
TSIDVLCVTASIETLCVIAVDRYFAIT 
AAVDVLCCTASILSLCAISIDRYIGVR 
LALDVLFCTSSIVHLCAISLDRYWSIT 
LALDYUASNASVMNLLLISFDRYFSVT 
NLFPITAMFVSIYSMTAIAADRYNAIV 
GFFTVFASELSVYTLTVITLERWHTIT 
GFFTVFASELSVYTLTVITLERWHTIT 
CTC ACA GTC ATC ACA CTA GAA AGA 
-- G m-G ..T . . . w-C -.G ._. -.G 
G TC CC CC T CC 
5’ GGA TCC CT1 AIA GTC ATG ACA GTI GAI ACA 3’ 
FMTIPAFFAKTSAVYNPVIYIMM 
LFVFFNWLGYANSAFNPIIY-CR 
VYILLNWIGYVNSGFNPLIY-CR 
VFKWFWLGYFNSCLNPIIYPCS 
LFKFFFWFGYCNSSLNPVIYTIF 
LWELGYWLCYVNSTINPMCYALC 
VYLALFWLAMSSTNYNPIIYCCL 
LLVLFY--- PVNSCANPFLYAIF 
LLVLFY--- PVNSCANPFLYAIF 
TCT TGT GCC AAT CCC TTT CTA TAC 
-.. ..- .-- --- --A .__ __G __T 
T CGG G GC 
3’ AGA ACA IAG TTA Ccl IAA TAI ATG CTT AAG 5’ 
Fig. I. Design of consensus oligonucleotides for amplification of TSH-R cDNA, derived from alignments of transmembrane r gions of different 
G-protein coupled receptors. These are bRHOD, bovine rhodopsin; hBETA1, human 01 adrenergic receptor; hBETA2, human 02 adrenergic 
receptor; hALPHA1, human cul adrenergic receptor; hALPHA2, human 012 adrenergic receptor; pm3ACH, porcine muscarinic holinergic recep- 
tor; bSK, bovine substance K receptor; pLH/hCG, porcine lutropin/human choriogonadotropin receptor (derived from [13]); rLH/hCG, rat 
lutropin/human choriogonadotropin receptor (derived from [12]). The aligned regions represent transmembrane r gions 2,3,6 and 7 and are term- 
ed TM2, TM3, TM6 and TM7, respectively. The amino acids underlined in the alignments represent some of the homologous residues selected 
for the consensus oligonucleotides. The nucleotide sequences below these amino acids represent the sequence of the cDNA at that region of porcine 
LH/hCG (upper) and rat LH/hCG (below) receptors. The dashes (---) represent aligned identical nucleotides. The consensus oligonucleotide shows 
the design of the mixed probe (degenerate) and inosine containing oligonucleotide derived from the alignment. The underlined nucleotides comprise 
the restriction enzyme sites; a BumHI site in the forward primers TM2 and TM3 and an EcoRI site in the reverse primers TM6 and TM7. 
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the correct size of approximately 700 bp using primers 
TM2 and TM7 only (Fig. 2). The use of other primer 
combinations TM2/TM6, TM3/TM6 and TM3/TM7 
did not yield any specific amplified products (not 
shown). Complex amplification protocols from cDNA 
using degenerate, inosine containing primers are ex- 
ceedingly susceptible to minute changes in Mg2 + con- 
centration, template and primer concentrations and 
other variables such as the enzyme concentration. Our 
attempts to amplify any product under a variety of con- 
ditions using the latter combinations of primers have 
been unsuccessful. Additionally, the use of all combina- 
tions of the primers described above for RACE 
PCR[ 161 amplification of TSH-R have also been unsuc- 
cessful. 
The amplified DNA fragments using primers TM2 
and TM7 were sequenced to identify the G-protein 
receptor family. Twenty seven different clones contain- 
ing the amplified cDNAs were sequenced. This revealed 
that the amplified cDNAs fall into 8 different groups 
(Table I). Groups CT1 (7 clones) and CT2 (3 clones) 
were in complete concordance within the transmem- 
brane regions 2 and 7 to the hTSH-R and p2-adrenergic 
receptor family, respectively [22,23,28]. Group CT4 (4 
clones) showed a limited homology with human early 
growth response factor 2 (EGR-2) [29] and the Krox-20 
protein containing zinc fingers [30]. Groups CT3 and 
GT5-CT8 did not show any homology to any of the 
gene sequences in the database. 
The publication of the complete nucleotide sequences 
of the dog and the human TSH-R allowed us to com- 
pare the sequences of our amplified products to the 
published TSH-R sequences. Parmentier et al. used 
degenerate oligonucleotides spanning transmembrane 
regions 2 and 7 to amplify material from human 
genomic DNA [ 191. Using an amplified cDNA frag- 
ment (which they now believe to be FSH-R [19]) as a 
probe, to screen a dog cDNA library at low stringency, 
they unambiguously identified two related dog TSH-R 
cDNAs [19,20]. Screening of a human thyroid cDNA 
library with dog TSH-R cDNA as a probe led to the 
isolation of the human hTSH-R [21]. Using a different 
strategy, based either upon the use of a full length 
cDNA probe to the LH/CG receptor [23] or 
oligonucleotides derived from that sequence [22], 
allowed two independent groups to identify a cDNA 
clone representing the hTSH-R from a human thyroid 
cDNA library [22,23]. Interestingly and importantly, all 
three cDNA clones to the hTSH-R are identical in 
amino acid sequence [2 l-231. 
Our results show that using degenerate 
oligonucleotide primers designed according to the 
strategies already described [17], a rare cDNA 
transcript such as the TSH-R can be specifically 
amplified and cloned. The availability of the full 
nucleotide sequence of the hTSH-R [22,23] allowed us 
to unambiguously confirm 7 of the 27 amplified cDNA 
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Fig.2. Ethidium bromide stained agarose g l to show in lane 2 the 700 
bp amplified cDNAs (arrowed) by a PCR from a human thyroid dou- 
ble stranded cDNA. The consensus oligonucleotide primers TM2 and 
TM7 were used. Lanes 1 and 3 are the 1 kb and the 123 bp ladders 
(BRL). 
clones to belong to the hTSH-R gene, without the need 
to identify a full length clone and functional expression 
data. Interestingly, a similar cloning strategy using 
degenerate oligonucleotide primers to transmembrane 
regions 3 and 6 described in [17], has allowed the clon- 
ing of an alternatively spliced member of another G- 
protein coupled receptor, the dopamine DZ receptor of 
rat brain [31]. Additionally amplification of unique 
members of the protein tyrosine kinase family has also 
been described using degenerate oligonucleotides deriv- 
ed from highly conserved sequence motifs of members 
of this family [32]. The method described herein and 
Table 1 
Derivation of the twenty seven cDNA clones amplified with TM2 and 
TM7 primers into eight distinct groups and their homologies where 
they exist with the published sequences. 
Group Number of clones Homology 
GTl 7 hTSH-R [22,23] 
GT2 3 02 adrenergic receptor [27] 
GT3 6 unknown 
GT4 4 limited similarity with early growth 
response gene-2 (EGR-2) [29] and 
Krox-20 protein containing zinc 
finger [30] 
GT5 3 unknown 
GT6 1 unknown 
GT7 2 unknown 
GT8 1 unknown 
The hTSH-R amplified clone of group GTl was fully sequenced 
whilst all the remaining clones were partially sequenced (minimum 
250 bp from 670 bp amplified DNA). 
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1463 1513 
hTSH-R 5' AACCTGGCCTTTGCGGATTTCTGCATGGGGATGTACCTGCTCCTCATCGCC....... 
1 50 
GT1.l 5' AATCTCGCCTTTGTGCATTTGTGCATGGGGATGTACCTGCTCCTCATCGCC...,.., 
to GTIL.7 
. . . . . . 2083 2133 
TTGCTGGTACTCTTCTATC~CTTMCTCCTGTGCC~TCCATTCCTCTAT 3' hTSH- 
. . . . . ..620 670 
TTGCTGGTACTCTTCTATCCACTTAACTCTCTGGCCCC~CCCCCTTATCTAC 3'GTl.l 
to GTf.7 
Fig.3. Nucleotide sequence of the CT1 clones amplified from thyroid cDNA with TM2 and TM7 primers. The sequence of ah 7 GTI clones termed 
GTI. 1 to GTl.7 were identical, The nucleotide sequence of the 670 bp GTl clones is shown from residue 1 to 50 and from 620 to 670. Directly 
above is the nucleotide sequence of the published human TSH-R [22,23] from residue 1463 to 1513 and 2083 to 2133 (encompassing transmembrane 
regions 2 and 7). The underlined nucleotides in the GTl clones represent he primer sequences used for amplification. The sequences between the 
primer residues in GTL clones were identical in sequence to the published TSH-R sequence. 
those of 117,321 are applicable to cloning other rare 
cDNA transcripts belonging to families of other related 
proteins for which there may be some sequence infor- 
mation. 
The nucleotide sequences of the groups GT3 and GT5 
to GT8 are being deposited at the EMBL Database 
Library. 
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